Hysteroscopes Market

Hysteroscopes Market Outlook (2022-2032)

The global hysteroscopes market is valued at US$ 265.5 million in 2022. Worldwide demand for hysteroscopes is predicted to increase at a CAGR of 5% and reach a market valuation of US$ 432.5 million by the year 2032.

Hysteroscopes are classified into rigid hysteroscopes and flexible hysteroscopes. Sales of rigid hysteroscopes are expected to rise at a healthy CAGR of 6% from 2022 to 2032. Rigid hysteroscopes are medical equipment used in both diagnostic and treatment procedures, this dual features support their demand. Flexible hysteroscopes are less durable than rigid hysteroscopes.

The removal of polyps, fibroids, and uterine cancer are some of the uterine problems that can be treated with rigid hysteroscopes. Flexible video hysteroscopes or rigid video hysteroscopes are also used to detect and treat uterine abnormalities.

• A fibroid may develop in at least 2 out of 3 women at some point in their lives, according to the National Health Service (NHS) 2022.
• Such a condition is mostly seen in women between the ages of 30 and 50. Women of African and Caribbean descent are most likely to get affected by fibroid.

As the number of fibroid cases rises, the demand for rigid hysteroscopes is expected to rise for diagnosis and treatment purposes. Thus, the above factors are expected to accelerate the sales of rigid hysteroscopes during the forecast period.

An endoscope is used during a hysteroscopy procedure to inspect the uterine wall. Three components make up a hysteroscope: a light source, a tube, and a lens, which is typically a tiny camera and fiber optics. Both rigid and semi-rigid types can be distinguished by tube flexibility.

Hysteroscopy has been linked to faster recovery, hardly any hospital stays, and significantly less blood loss. Thus, this minimally-invasive surgical method is preferred because it results in less discomfort after surgery and allows the patient to return to their regular activities more quickly than traditional invasive procedures. Additionally, hysteroscopy enables gynaecologists to assess endometrial health and formulate a surgical treatment plan. Low cost, reliability, and comfort make hysteroscope devices, effective surgical tools.

A hysteroscopy is also utilized to examine the uterus to diagnose anomalies such as heavy bleeding, excruciating cramps, recurrent miscarriages, difficulties getting pregnant, and endometrial malignancies.

Rising prevalence of endometrial cancer is likely to boost the sales of hysteroscopes during the projected period.

• Endometrial cancer incidence is predicted to rise by more than 50% globally by 2040, according to the International Agency for Research on Cancer's 2020 report.

The sector is also flourishing as a result of rising demand for minimally-invasive diagnostic and therapeutic tools and technological advancements in hysteroscopes to develop advanced features.

• Aveta System a see-and-treat resecting hysteroscope with HD vision and the smallest insertion diameter was unveiled in March 2020 by Meditrina Inc.

Thus, rising cases of endometrial cancer, technological breakthroughs, and rising demand for minimally-invasive surgical procedures are expected to boost the production of hysteroscopes.

Major hysteroscope suppliers in European countries such as Germany and the U.K. continuously focus on launching advanced hysteroscopes. Karl Storz GmbH & Co. KG is one of the top producers of hysteroscopes in the region.

Report Attributes	Details
Hysteroscopes Market Size (2022E)	US$ 265.5 Million
Forecasted Market Value (2032F)	US$ 432.5 Million
Global Market Growth Rate (2022-2032)	5% CAGR
China Market Growth Rate (2022-2032)	8% CAGR
Key Companies Profiled	B. Braun Melsungen AG Boston Scientific Corporation Ethicon US LLC Hologic, Inc. Karl Storz GmbH & Co. KG Medtronic PLC Olympus Corporation Richard Wolf GmbH Stryker Corporation The Cooper Companies, Inc.

What is Aiding Growth of the Demand for Hysteroscope Devices?

“Rising Cases of Uterine Fibroids & Uterine Polyps”

Growths in the uterus' inner lining (endometrium) are known as uterine polyps. They extend inward into the uterus and are joined to the endometrium by a narrow stalk or a large base. Although uterine polyps are often noncancerous, if left untreated, they may affect fertility or menstruation.

Depending on their size, polyps can be round or oval and can be as small as a few millimetres (the diameter of a sesame seed) or as large as a few centimetres (the diameter of a golf ball). One can get infected with a singular polyp or numerous. A polypectomy procedure is performed to remove the polyp.

Also, uterine fibroids are the most common ailments experienced by females. Obesity, early onset of menstruation, and late age of menopause are some of the reasons behind them. Uterine fibroids may rarely transform into a cancerous tumour. Hysteroscopic myomectomy procedures are suggested by doctors for the treatment of submucosal fibroids

Thus, the rising prevalence of uterine fibroids and uterine polyps is expected to boost sales of hysteroscopes.

“Increasing Incidence of Endometrial Ablation Procedures”

Endometrial ablation procedures are performed to stop excessive menstrual blood loss. Heavy blood loss, a longer period of bleeding of more than 8 days, and anemia are some of the symptoms when doctors suggest endometrial ablation treatment.

Thus, the rising incidences of abnormal uterine bleeding, heavy menstrual bleeding, irregular spotting between periods, and bleeding after menopause among women are some of the factors supporting the growth of the hysteroscopes market.

Which Challenges are Faced by Hysteroscope Device Producers?

“High Product Cost & Chances of Side Effects of Hysteroscopy Procedures”

The high cost of hysteroscopy, the rising risk of side effects from hysteroscopy procedures, and the availability of alternative options for the diagnosis and treatment of gynaecological conditions are some of the factors that will hamper the global hysteroscope market growth.

Furthermore, increasing infrastructural gaps for surgical procedures in developing nations and a growing shortage of gynaecologists will pose additional challenges to hysteroscope suppliers.

Country-wise Analysis

Why are Suppliers of Hysteroscopes Attracted to North America?

“Presence of Well-established Healthcare Facilities & Rising Prevalence of Endometrial Malignancies”

Countries in North America such as the United States and Canada have sophisticated healthcare systems. As a result, there are considerable investments made in the research and development of technologies that are less invasive and more efficient.

Rising cases of uterine or endometrial malignancies in the North American region are increasing the demand for diagnostic hysteroscopes.

• Uterine cancer, also known as endometrial cancer, is likely to affect 65,950 individuals in the United States in 2022, according to the American Society of Clinical Oncology's publication Uterine Cancer: Statistics 2022.
• According to a report from the international journal of gynecology and obstetrics titled "Cancer of the corpus uteri: 2021 update" which was released in October 2021, endometrial cancer, is the most common form of cancer found in the female genital tract and is the fifth most commonly seen cancer in women after breast, colorectal, lung, and non-basal skin cancer, and is most common in North America.

As a result, there will be a greater need for diagnostic and therapeutic hysteroscopy equipment for uterine or endometrial cancer treatment, which will accelerate hysteroscopy instruments market growth in the region.

What is Accelerating Sales of Hysteroscopy Systems in Asian Countries?

“Rising Cases Related to Infertility & Gynecologic Cancer”

Demand for hysteroscopes in Asia Pacific countries such as India, China, Japan, and South Korea is increasing due to factors such as rising cases of uterine cancer, awareness regarding personal hygiene care, respective government initiatives for reimbursement, and rising incidences of infertility & other associated disorders.

For instance, gynecologic cancer is becoming more common in Japan, and this condition has gained top rank in terms of mortality.

• In Japan treatment recommendations for ovarian cancer, endometrial cancer, and cervical cancer were initially released by the Japan Society of Gynecologic Oncology (JSOG) in 2004, 2006, and 2007, respectively. These recommendations are updated every three years.

Category-wise Analysis

Will Rising Number of Myomectomy Procedures Push Sales of Hysteroscopes?

“Rising Worldwide Prevalence of Uterine Fibroids”

Rising cases of uterine fibroids worldwide accelerate the number of myomectomy procedures. In terms of revenue share, myomectomy currently dominates the hysteroscopy procedures market.

Treatments for a variety of clinical disorders, including protracted infertility, and uterine fibroids, include hysteroscopy. This process is useful in determining the reason for repeated miscarriages. It aids in assessing female pelvic pain as well.

In some instances, surgical hysteroscopy is also used to remove adhesions, which are uterine scar tissues. Diagnostic hysteroscopy can also be used to do an operational hysteroscopy, preventing the need for additional surgery.

Why are Hysteroscopes Most Widely Used by Hospitals and Gynecology Clinics?

“Presence of Skilled Medical Experts & Advanced Medical Technologies Attract Target Patients”

Hospitals and gynecology clinics currently dominate sales of hysteroscopes. The presence of diverse medical equipment and skilled doctors, together with the increased number of hospitalizations for treating gynaecological problems, are driving up demand for hysteroscopes.

Thus, the availability of advanced and effective treatment at affordable cost increases the demand for hysteroscopes from hospitals and gynecology clinics.

Competitive Landscape

B. Braun Melsungen AG, Boston Scientific Corporation, Ethicon US LLC, Hologic, Inc., Karl Storz GmbH & Co. KG, Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Stryker Corporation, and The Cooper Companies, Inc. are some of the key players in the hysteroscopes market.

Top firms already hold a dominant foothold in the industry and create strong competition for new entrants. They are investing heavily in research and development to produce improved hysteroscope devices.

• 'Hystero-V', a single-use, semi-rigid hysteroscope which is consistent with UroViu's Always Ready endoscopy platform was introduced by UroViu Corp in June 2022. The 12-Fr, semi-rigid Hystero-V has a hydrophilic covering that allows for gentle insertion and excellent visualisation for extremely successful intrauterine examinations.

Key Segments of Hysteroscopes Industry Research

• By Product Type:

  • Rigid
  • Flexible

• By Application:

  • Myomectomy
  • Diagnostic
  • Operative
  • Polypectomy
  • Endometrial Ablation

• By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Gynecology Clinics
  • Others

• By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA